About Visiogen
Visiogen is a company based in Irvine (United States) founded in 2001 was acquired by Abbott in September 2009. Visiogen has raised $40 million across 1 funding round from investors including Abbott, New Leaf Venture Partners and Novartis Venture Fund. Visiogen operates in a competitive market with competitors including RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Visiogen Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Visiogen
Visiogen has successfully raised a total of $40M through 1 strategic funding round. The most recent funding activity was a Series C round of $40 million completed in April 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Visiogen
Visiogen has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott, New Leaf Venture Partners and Novartis Venture Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in innovative life science companies globally.
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in companies in the US
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are managed.
|
Locked | Locked | Locked |
Investor details for Visiogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Visiogen
Investment portfolio details for Visiogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Visiogen
Detailed financials for Visiogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Visiogen Comparisons
Peer comparison for Visiogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Visiogen
Visiogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adjustable intraocular lens technology is developed using UV-sensitive macromers.
|
|
| Locked | Locked | Locked |
A presbyopia-correcting intraocular lens is developed for cataract patients.
|
|
| Locked | Locked | Locked |
Manufacturer of implantable lenses for the eye with companion delivery systems
|
|
| Locked | Locked | Locked |
Artificial intraocular lenses for cataract treatment are developed.
|
|
| Locked | Locked | Locked |
Intraoperative guidance for IOL alignment in cataract surgery is offered.
|
|
| Locked | Locked | Locked |
Manufacturer of intraocular lenses and related products
|
Detailed competitors of Visiogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Visiogen
Complete news archive for Visiogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Visiogen
Visiogen was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Visiogen is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Visiogen is a funded company, having raised a total of $40M across 1 funding round to date.
Visiogen was established in 2001 in Irvine, United States, within the ophthalmic medical device sector. The Synchrony dual optic accommodating intraocular lens was created for surgical cataract treatment addressing presbyopia. Seamless vision across near, intermediate, and distance ranges was enabled without glasses or contacts. The lens was delivered via a pre-loaded injector system. Acquisition by Abbott took place in 2009.
Visiogen's top competitors include RxSight, Nayam Innovations and Atia Vision.
Visiogen has 8 investors. Key investors include Abbott, New Leaf Venture Partners, Novartis Venture Fund, Three Arch Partners, and Prospect Venture Partners.